The Buzz, Issue #8 is now out! This issue features new international urticaria guidelines, a trial of convalescent plasma in COVID-19, and new publications on peanut immunotherapy, food allergy desensitization, and combination treatment for allergic rhinitis.

~ hivecanada

The Buzz Issue #8, October 2021 edition, will be sent to all HIVE members by email on Tuesday, October 26th, and can be accessed online here. This edition covers:

  • Updated guidelines for chronic urticaria
  • The CONCOR-1 study of convalescent plasma for COVID-19 treatment
  • Post-hoc analysis of allergic reaction severity from a peanut immunotherapy study
  • Dupilumab and subcutaneous immunotherapy for allergic rhinitis
  • Future strategies in food allergy desensitization

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #7 is now out! In this issue we feature five new publications with high clinical relevance for Canadian allergists.

~ hivecanada

The Buzz Issue #7, September 2021 edition, will be sent to all HIVE members by email on Tuesday, September 14th, and can be accessed online here. This edition covers:

  • Challenges and success in implementing the findings from LEAP
  • Using graded oral challenge to confirm hypersensitivity to amoxicillin
  • Clinical and demographics characteristics of HAE patients in Canada
  • Comorbid autoimmune diseases in Type IIb autoimmune CSU
  • Review of urticarial vasculitis

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.

~ hivecanada

The Buzz Issue #6, August edition, will be sent to all HIVE members by email on Monday, July 26, and can be accessed online here. This edition covers:

  • Seroconversion following vaccination for patients on anti-CD20 therapy
  • Association between meconium metabolome and atopy in Canadian infants
  • Context for a network meta-analysis of antihistamines in chronic spontaneous urticaria
  • Case series and systematic review of omalizumab for idiopathic anaphylaxis
  • Review on allergic rhinitis management

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #5 is now available! In this issue, we highlight new publications in urticaria, angioedema, asthma and draw attention to the new food allergy guidelines for childcare centres and schools.

~ hivecanada

The Buzz Issue #5, July edition, was sent to all HIVE members by email on Monday, June 28, and can be accessed online here. This edition covers:

  • Urticaria disease activity during and after pregnancy
  • A practical approach to identifying angioedema and urticaria mimics
  • Conditional recommendations on the prevention and management of allergic reactions in schools and childcare centers
  • Prestudy treatment effect on the SYGMA 1 and 2 outcomes

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #4 is now available! In this issue, we have five new articles to bring to the attention of Canadian allergists.

~ hivecanada

The Buzz Issue #4, June edition, was sent to all HIVE members by email on Monday, May 31, and can be accessed online here. This edition covers:

  • Pathogenic differentiation of CHA and CSU
  • Considerations for proceeding with or delaying the COViD-19 mRNA vaccine booster following a suspected anaphylactic event
  • Case reports of omalizumab exposure in pregnancy
  • Pediatric DRESS following penicillin-based therapy
  • Hereditary angioedema in the emergency department

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #3 is now available! In this issue, we highlight 5 new articles clinically relevant for Canadian allergists.

~ hivecanada

The Buzz Issue #3, May edition, was sent to all HIVE members by email on Monday, May 3, and can be accessed online here. This edition covers:

  • Evidence review in pediatric chronic spontaneous urticaria
  • An allergists guide to biologic economic analyses
  • Practical consensus recommendations for implementing oral immunotherapy
  • Updated contact dermatitis patch test results
  • Humoral immunity against SARS-CoV-2 in Canadian patients

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #2 is now available! Check out this month’s selection of new publications clinically relevant to Canadian allergists, immunologists and dermatologists.

~ hivecanada

The Buzz Issue #2, April edition, was sent to all HIVE members by email on Monday, March 29, and can be accessed online here. This edition covers:

  • The allergists’ perspective on anaphylaxis risk with SARS-CoV-2 vaccines
  • Emerging biologics for chronic spontaneous urticaria
  • Predictors of response and non-response in chronic spontaneous urticaria
  • Real-world analysis of omalizumab in chronic inducible urticaria
  • Quantifying peanut allergen thresholds in Canadian children and young adults

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz